Matches in SemOpenAlex for { <https://semopenalex.org/work/W2514152755> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2514152755 abstract "Certain anticancer drugs are known to induce leg ulcers, mainly chemotherapy agents such as hydroxyurea. We report 2 cases of leg ulcers in cancer patients treated with the tyrosine kinase inhibitors, sunitinib and nilotinib, and we discuss the role of these treatments in the pathogenesis of leg ulcers.Case 1. A 62-year-old patient on sunitinib for intrahepatic cholangiocarcinoma developed a lesion on her right foot. The vascular evaluation was negative. After progressive worsening, sunitinib was stopped and healing was observed within a few months. Case 2. A 83-year-old patient had been treated for chronic myeloid leukemia since 2005. Nilotinib was introduced in 2009. Peripheral arterial revascularization was required in May 2013. A few months later, worsening was noted with the onset of ulceration and necrosis of the third toe. Further revascularisation surgery was performed, and nilotinib was suspended and antiplatelets introduced. Healing occurred a few months later.Many skin reactions have been described in patients on nilotinib and sunitinib, but few publications report the development of de novo ulcers in patients without risk factors. The pathophysiology of the development of ulcers in patients receiving tyrosine kinase inhibitors is not clear, and probably involves several mechanisms of action. The increasing use of this type of treatment could lead to an upsurge in the incidence of vascular complications.We report two cases of leg ulcers developing in patients on tyrosine kinase inhibitors and raise the question of causal implication of these treatments in the pathogenesis of ulcers." @default.
- W2514152755 created "2016-09-16" @default.
- W2514152755 creator A5007427635 @default.
- W2514152755 creator A5009106809 @default.
- W2514152755 creator A5034415096 @default.
- W2514152755 creator A5060752154 @default.
- W2514152755 creator A5061773309 @default.
- W2514152755 creator A5065839239 @default.
- W2514152755 creator A5068680117 @default.
- W2514152755 creator A5070004586 @default.
- W2514152755 creator A5090097818 @default.
- W2514152755 date "2017-01-01" @default.
- W2514152755 modified "2023-10-04" @default.
- W2514152755 title "Ulcères des membres inférieurs développés sous inhibiteurs de tyrosine kinase (sunitinib, nilotinib)" @default.
- W2514152755 cites W1560427955 @default.
- W2514152755 cites W1953977402 @default.
- W2514152755 cites W1971339433 @default.
- W2514152755 cites W1974941790 @default.
- W2514152755 cites W1975058097 @default.
- W2514152755 cites W1987134816 @default.
- W2514152755 cites W2002740364 @default.
- W2514152755 cites W2006152358 @default.
- W2514152755 cites W2012324155 @default.
- W2514152755 cites W2013973828 @default.
- W2514152755 cites W2014329705 @default.
- W2514152755 cites W2019192605 @default.
- W2514152755 cites W2029876904 @default.
- W2514152755 cites W2037603534 @default.
- W2514152755 cites W2046509298 @default.
- W2514152755 cites W2051566553 @default.
- W2514152755 cites W2055030955 @default.
- W2514152755 cites W2068248632 @default.
- W2514152755 cites W2069714238 @default.
- W2514152755 cites W2078592499 @default.
- W2514152755 cites W2078646947 @default.
- W2514152755 cites W2079209678 @default.
- W2514152755 cites W2082731686 @default.
- W2514152755 cites W2093608520 @default.
- W2514152755 cites W2106913797 @default.
- W2514152755 cites W2112762663 @default.
- W2514152755 cites W2122549521 @default.
- W2514152755 cites W2140259730 @default.
- W2514152755 cites W2152174806 @default.
- W2514152755 cites W2254132687 @default.
- W2514152755 cites W2326428571 @default.
- W2514152755 cites W2462215410 @default.
- W2514152755 cites W2766879274 @default.
- W2514152755 doi "https://doi.org/10.1016/j.annder.2016.06.009" @default.
- W2514152755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27527566" @default.
- W2514152755 hasPublicationYear "2017" @default.
- W2514152755 type Work @default.
- W2514152755 sameAs 2514152755 @default.
- W2514152755 citedByCount "2" @default.
- W2514152755 countsByYear W25141527552018 @default.
- W2514152755 crossrefType "journal-article" @default.
- W2514152755 hasAuthorship W2514152755A5007427635 @default.
- W2514152755 hasAuthorship W2514152755A5009106809 @default.
- W2514152755 hasAuthorship W2514152755A5034415096 @default.
- W2514152755 hasAuthorship W2514152755A5060752154 @default.
- W2514152755 hasAuthorship W2514152755A5061773309 @default.
- W2514152755 hasAuthorship W2514152755A5065839239 @default.
- W2514152755 hasAuthorship W2514152755A5068680117 @default.
- W2514152755 hasAuthorship W2514152755A5070004586 @default.
- W2514152755 hasAuthorship W2514152755A5090097818 @default.
- W2514152755 hasConcept C29456083 @default.
- W2514152755 hasConcept C71924100 @default.
- W2514152755 hasConceptScore W2514152755C29456083 @default.
- W2514152755 hasConceptScore W2514152755C71924100 @default.
- W2514152755 hasLocation W25141527551 @default.
- W2514152755 hasLocation W25141527552 @default.
- W2514152755 hasOpenAccess W2514152755 @default.
- W2514152755 hasPrimaryLocation W25141527551 @default.
- W2514152755 isParatext "false" @default.
- W2514152755 isRetracted "false" @default.
- W2514152755 magId "2514152755" @default.
- W2514152755 workType "article" @default.